Clinical Trial Update: A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating the safety and efficacy of Synvisc for symptomatic ankle osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED